Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anthracycline-induced Cardiac Toxicity”

75 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 75 results

Not applicableLooking for participantsNCT06282796
What this trial is testing

Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

Who this might be right for
Breast Cancer
First Hospital of China Medical University 600
Not applicableStudy completedNCT03166813
What this trial is testing

Remote Ischaemic Preconditioning in Childhood Cancer

Who this might be right for
Cardiotoxicity
The University of Hong Kong 68
Not applicableEnded earlyNCT00679874
What this trial is testing

Assessment of Cardiotoxicity After Chemotherapy for Breast Cancer by Cardio-vascular Magnetic Resonance (MR)

Who this might be right for
Breast Cancer
University of Calgary 66
Post-approval studies (Phase 4)Study completedNCT02053974
What this trial is testing

Spironolactone Against Anthracycline-induced Cardiomyopathy

Who this might be right for
Anthracycline Induced Cardiotoxicity
TC Erciyes University 90
Not applicableUnknownNCT03155802
What this trial is testing

Novel Biomarkers and Echocardiography for Subclinical Cardiac Toxicity in Breast Cancer Patients Receiving Anthracyclines

Who this might be right for
CardiotoxicityHeart FailureBreast Cancer+3 more
Stony Brook University 35
Not applicableLooking for participantsNCT05703126
What this trial is testing

Clinical and Diagnostic Significance of Endothelial Dysfunction and Myocardial Contractility in Patients With AML

Who this might be right for
Acute Myeloid Leukemia, AdultCardiotoxicityEndothelial Dysfunction
Samara State Medical University 100
Large-scale testing (Phase 3)UnknownNCT05792293
What this trial is testing

Role of Statin Therapy in Prevention of Anthracycline-Induced Cardiotoxicity

Who this might be right for
Doxorubicin Induced Cardiomyopathy
Ain Shams University 100
Large-scale testing (Phase 3)Looking for participantsNCT06214195
What this trial is testing

The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity

Who this might be right for
Cardiotoxicity Induced by Drug Therapy for Breast Cancer
Zhejiang Cancer Hospital 276
Large-scale testing (Phase 3)Study completedNCT05175066
What this trial is testing

Bisoprolol Administration to Prevent Anthracycline-induced Cardiotoxicity

Who this might be right for
CardiomyopathiesChemotherapy EffectDiastolic Dysfunction+1 more
Shahid Beheshti University of Medical Sciences 80
Not applicableStudy completedNCT05923242
What this trial is testing

Translating ECHOS2 Into an mHealth Platform

Who this might be right for
Childhood CancerCardiac ToxicityPediatric Cancer
Washington University School of Medicine 73
Testing effectiveness (Phase 2)UnknownNCT03186404
What this trial is testing

Statins for the Primary Prevention of Heart Failure in Patients Receiving Anthracycline Pilot Study

Who this might be right for
CancerHeart FailureCardiotoxicity
University Health Network, Toronto 112
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07370506
What this trial is testing

Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients

Who this might be right for
Breast CancerDoxorubicin Induced Cardiomyopathy
Tanta University 36
Not applicableStudy completedNCT01805778
What this trial is testing

Preventing Cardiac Sequelae in Pediatric Cancer Survivors

Who this might be right for
Anthracycline-induced Cardiotoxicity
The Hospital for Sick Children 1,128
Testing effectiveness (Phase 2)Study completedNCT01095926
What this trial is testing

Pharmacokinetic Study of Doxorubicin in Children With Cancer

Who this might be right for
Wilms TumorNeuroblastomaSoft Tissue Sarcoma+1 more
University Hospital Muenster 101
Not applicableEnded earlyNCT05781672
What this trial is testing

Prediction of Delayed Toxic Cardiomyopathy in Children

Who this might be right for
CardiotoxicityChildhood Cancer
University Hospital, Montpellier 134
Large-scale testing (Phase 3)Active Not RecruitingNCT05271162
What this trial is testing

Empagliflozin in the Prevention of Cardiotoxicity in Cancer Patients Undergoing Chemotherapy Based on Anthracyclines

Who this might be right for
Cardiotoxicity
Maria Sklodowska-Curie National Research Institute of Oncology 220
Not applicableActive Not RecruitingNCT07442578
What this trial is testing

Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial

Who this might be right for
Childhood Cancer SurvivorsCardiotoxicityCardiovascular Diseases+1 more
Dana-Farber Cancer Institute 20
Not applicableUnknownNCT01032278
What this trial is testing

Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT)

Who this might be right for
Cardiac ToxicityUnspecified Adult Solid Tumor, Protocol Specific
M.D. Anderson Cancer Center 597
Not applicableEnded earlyNCT00728429
What this trial is testing

Aerobic Exercise in Patients Receiving Chemotherapy for Cancer

Who this might be right for
Cardiac ToxicityChemotherapeutic Agent ToxicityUnspecified Adult Solid Tumor, Protocol Specific
Wake Forest University Health Sciences 1
Large-scale testing (Phase 3)Looking for participantsNCT06220032
What this trial is testing

Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell Lymphoma

Who this might be right for
DLBCL - Diffuse Large B Cell Lymphoma
Stichting Hemato-Oncologie voor Volwassenen Nederland 324
Next Page